A $4 million verdict has been reached in a Topamax lawsuit against Johnson & Johnson’s Pharmaceutical unit Janssen.
On October 30 , 2013, a Philadelphia jury sided with the woman who took Topamax for six months during her pregnancy and gave birth to a boy with cleft lip. The suit alleged Janssen’s flawed drug Topamax was the cause of a severe birth defect in a baby boy. Four surgeries were needed to correct the extensive injury.
The Plaintiff’s attorney stated ...
continue reading...
